Cape Town, South Africa

Bronwen Miller

USPTO Granted Patents = 5 

 

Average Co-Inventor Count = 5.9

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2021-2025

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Bronwen Miller: Innovator in Target Enrichment Technologies

Introduction

Bronwen Miller is a prominent inventor based in Cape Town, South Africa. She has made significant contributions to the field of molecular biology, particularly in the area of target enrichment technologies. With a total of five patents to her name, Miller's work has advanced the methods used in genetic research and diagnostics.

Latest Patents

Miller's latest patents include innovative methods and compositions for primer extension target enrichment of target polynucleotides. One of her notable inventions is a method for enrichment of at least one target nucleic acid in a library of nucleic acids. This method involves hybridizing a first oligonucleotide to a target nucleic acid, extending it with a polymerase, and capturing the resulting primer extension complex. This process enhances the enrichment of the target nucleic acid, allowing for more precise genetic analysis.

Career Highlights

Throughout her career, Bronwen Miller has worked with leading companies in the biotechnology sector. She has been associated with Roche Sequencing Solutions, Inc. and Kapa Biosystems, Inc., where she has contributed her expertise in developing advanced sequencing technologies. Her work has been instrumental in improving the efficiency and accuracy of genetic testing.

Collaborations

Miller has collaborated with notable professionals in her field, including Brian Christopher Godwin and Joseph Platzer. These collaborations have further enriched her research and development efforts, leading to groundbreaking advancements in target enrichment methodologies.

Conclusion

Bronwen Miller's innovative contributions to the field of molecular biology have established her as a key figure in the development of target enrichment technologies. Her patents and collaborations reflect her commitment to advancing genetic research and diagnostics.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…